<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To review the early diagnosis and early effective treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its role in reducing the risk of complications </plain></SENT>
<SENT sid="1" pm="."><plain>This article discusses the diagnosis of T2D and the initial stages of disease management with oral monotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>DATA SOURCES: Extensive literature review of textbooks and clinical, medical, and nursing journals </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSIONS: There are clear evidence-based recommendations for disease management in the early stages of T2D, with therapy focusing on implementation of lifestyle changes and use of pharmacologic monotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>A vital part of early T2D treatment is patient education, which can lay the foundation for treatment throughout the disease continuum </plain></SENT>
<SENT sid="5" pm="."><plain>The lifestyle changes recommended for management of T2D can be difficult for patients to sustain, and treatment regimens are often complex </plain></SENT>
<SENT sid="6" pm="."><plain>IMPLICATIONS FOR PRACTICE: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2D) is a progressive disease, associated with a long-term risk of morbidity and mortality </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, it is important that treatment is individualized, and that ongoing support is provided to maximize the possibility of achieving treatment goals </plain></SENT>
<SENT sid="8" pm="."><plain>Current standards for T2D treatment are designed for a patient-centered treatment approach managed by team of healthcare practitioners, in which the nurse practitioner (NP) is central </plain></SENT>
</text></document>